FOXK1 and Hepatic steatosis: Mice with hepatocyte-specific deletion of Foxk1 exhibit reduced lipogenic activities and increased catabolic activities, which are associated with protection from hepatic steatosis, inflammation, and fibrosis in pre-clinical MASLD models [62].